3
Announcements
Trials
Browse
Landscape
Status
Completed
432
Terminated
99
Recruiting
54
Unknown
41
Withdrawn
32
Active not recruiting
25
Not yet recruiting
6
Suspended
1
No longer available
1
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Acute
4
Hematologic Neoplasms
3
Myelodysplastic Syndromes
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Immunologic Deficiency Syndromes
2
Thalassemia
1
Recurrence
1
Multiple Myeloma
1
Metabolic Diseases
1
Mastocytosis, Systemic
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Leukemia, Plasma Cell
1
Leukemia, Mast-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Burkitt Lymphoma
1
Bone Marrow Failure Disorders
1
Anemia, Sickle Cell
1
Anemia, Aplastic
1
Amyloidosis
1
Adrenoleukodystrophy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Available
×
Burkitt Lymphoma
×
Other hematologic neoplasm
×
Clear all
NCT06799221
2026-02-27
Expanded Access Program for OOS Obe-cel
Autolus Limited
Available